REYKJAVIK, Iceland, Sept. 18, 2006 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, has noted the increased offer published on September 11th, to acquire PLIVA (LSE:PLVD) (ZSE:PLVA-R-A), announced by Barr Pharmaceuticals (NYSE:BRL).
